Cas:1070-01-5 N,N-didecyldecan-1-amine manufacturer & supplier

We serve Chemical Name:N,N-didecyldecan-1-amine CAS:1070-01-5 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

N,N-didecyldecan-1-amine

Chemical Name:N,N-didecyldecan-1-amine
CAS.NO:1070-01-5
Synonyms:Tris(decyl)amine;tridecylamine;EINECS 213-966-5;N,N,N-tri-decylamine;Tris-decyl-amin;1-Decanamine,N,N-didecyl;Tri-n-decylaMine;Tridecylamin;tri-n-decyl amine;TRIDECANITRILE (mixed isomers)
Molecular Formula:C30H63N
Molecular Weight:437.82800
HS Code:2921199090

Physical and Chemical Properties:
Melting point:-2ºC
Boiling point:504.4ºC at 760 mmHg
Density:0.824 g/cm3
Index of Refraction:1.454-1.456
PSA:3.24000
Exact Mass:437.49600
LogP:10.71050

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like Tris(decyl)amine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,TRIDECANITRILE (mixed isomers) physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Tri-n-decylaMine Use and application,tri-n-decyl amine technical grade,usp/ep/jp grade.


Related News: ��Ultimately, this is a public health decision,�� she said, adding that the restrictions were precautionary measures to keep the country virus-free and contain the worldwide outbreak. N,N-didecyldecan-1-amine manufacturer Patients given the vaccine also experienced a reduction in cerebrospinal fluid biomarkers of abnormal tau, results show. N,N-didecyldecan-1-amine supplier The target screening performed by Retrogenix will focus on hundreds of novel, prioritized antibodies in Resonant��s collection. N,N-didecyldecan-1-amine vendor ��Ultimately, this is a public health decision,�� she said, adding that the restrictions were precautionary measures to keep the country virus-free and contain the worldwide outbreak. N,N-didecyldecan-1-amine factory Patients given the vaccine also experienced a reduction in cerebrospinal fluid biomarkers of abnormal tau, results show.